Gabrielle Toledano Sells 616 Shares of IonQ (NYSE:IONQ) Stock

IonQ, Inc. (NYSE:IONQ) Director Gabrielle Toledano sold 616 shares of the stock in a transaction on Tuesday, February 24th. The shares were sold at an average price of $31.00, for a total value of $19,096.00. Following the completion of the transaction, the director owned 9,385 shares of the company’s stock, valued at $290,935. This trade represents a 6.16% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

IonQ Stock Performance

NYSE:IONQ opened at $33.63 on Thursday. The stock’s 50 day moving average price is $42.90 and its 200 day moving average price is $50.39. IonQ, Inc. has a 52 week low of $17.88 and a 52 week high of $84.64. The company has a market capitalization of $11.69 billion, a P/E ratio of -6.29 and a beta of 2.63.

Key IonQ News

Here are the key news stories impacting IonQ this week:

• Positive Sentiment: Q4 2025 results materially beat expectations: revenue $61.89M (≈+429% YoY) and non‑GAAP loss narrower than forecast, signaling strong commercial traction. IonQ Stock Rises on Earnings
• Positive Sentiment: Management issued upside guidance: FY2026 revenue guide $225–245M (midpoint ~22% above consensus) and Q1 revenue guide $48–51M, reinforcing revenue growth expectations. IonQ Announces Fourth Quarter and Full Year 2025 Financial Results
• Positive Sentiment: Won a spot on the U.S. Missile Defense Agency’s SHIELD IDIQ (ceiling $151B), which can enlarge federal opportunities and bolster credibility with defense customers. How Investors May Respond To IonQ Gaining Eligibility Under MDA SHIELD Contract
• Neutral Sentiment: Company is pursuing acquisitions, a foundry strategy and tech roadmap (256‑qubit milestones) to scale—these can be transformative but add integration and execution risk. IonQ Q4 2025 Earnings Call Highlights
• Negative Sentiment: Profitability remains a concern—very wide GAAP losses, negative margins and negative ROE persist despite revenue growth; valuation (large market cap) could be challenged if growth slows. MarketBeat Q4 Summary
• Negative Sentiment: Insider selling: director Gabrielle Toledano sold 616 shares (~$31 avg), a small stake reduction that may attract short‑term attention. Insider Sale Filing

Hedge Funds Weigh In On IonQ

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Vanguard Group Inc. grew its holdings in IonQ by 18.5% during the 4th quarter. Vanguard Group Inc. now owns 34,774,743 shares of the company’s stock valued at $1,560,343,000 after buying an additional 5,420,037 shares in the last quarter. Norges Bank bought a new position in IonQ during the 4th quarter worth approximately $199,753,000. Marex Group plc increased its stake in IonQ by 419.1% in the 4th quarter. Marex Group plc now owns 4,083,453 shares of the company’s stock worth $183,225,000 after purchasing an additional 3,296,866 shares during the period. State Street Corp raised its position in IonQ by 42.3% during the 4th quarter. State Street Corp now owns 8,962,789 shares of the company’s stock valued at $402,160,000 after purchasing an additional 2,663,230 shares during the last quarter. Finally, JPMorgan Chase & Co. increased its position in IonQ by 648.5% during the 2nd quarter. JPMorgan Chase & Co. now owns 2,674,348 shares of the company’s stock valued at $114,917,000 after purchasing an additional 2,317,058 shares during the period. Hedge funds and other institutional investors own 41.42% of the company’s stock.

Analyst Upgrades and Downgrades

IONQ has been the topic of several recent research reports. Weiss Ratings reiterated a “sell (d-)” rating on shares of IonQ in a research note on Thursday, January 22nd. Cantor Fitzgerald reiterated an “overweight” rating on shares of IonQ in a research note on Monday, February 9th. Wedbush initiated coverage on shares of IonQ in a research report on Wednesday, December 17th. They set an “outperform” rating and a $60.00 target price on the stock. Mizuho assumed coverage on shares of IonQ in a report on Thursday, December 11th. They set an “outperform” rating and a $90.00 target price on the stock. Finally, Morgan Stanley cut their price objective on shares of IonQ from $58.00 to $35.00 and set an “equal weight” rating for the company in a research report on Monday. Nine investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $73.82.

About IonQ

IonQ, Inc engages in the development of general-purpose quantum computing systems in the United States. It sells access to quantum computers of various qubit capacities. The company makes access to its quantum computers through cloud platforms, such as Amazon Web Services (AWS) Amazon Braket, Microsoft’s Azure Quantum, and Google’s Cloud Marketplace, as well as through its cloud service. It also provides contracts associated with the design, development, and construction of specialized quantum computing hardware systems; maintenance and support services; and consulting services related to co-developing algorithms on quantum computing systems.